Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2014, Article ID 195935, 10 pages
http://dx.doi.org/10.1155/2014/195935
Research Article

Redox Imbalance and Morphological Changes in Skin Fibroblasts in Typical Rett Syndrome

1Department of Molecular and Developmental Medicine, University of Siena, 53100 Siena, Italy
2Child Neuropsychiatry Unit, University Hospital Azienda Ospedaliera Universitaria Senese (AOUS), 53100 Siena, Italy
3Neonatal Intensive Care Unit, University Hospital AOUS, Policlinico “S. M. alle Scotte,” 53100 Siena, Italy
4Medical Genetics, University of Siena, 53100 Siena, Italy
5Department of Life Sciences, University of Siena, 53100 Siena, Italy
6Department of Medicine Surgery and Neuroscience, University of Siena, 53100 Siena, Italy
7Department of Life Science and Biotechnologies, University of Ferrara, 44121 Ferrara, Italy
8Institut des Biomolécules Max Mousseron (IBMM), UMR 5247-CNRS-UM I-UM II-ENSCM, BP 14491 34093, Montpellier Cedex 5, France
9Genetica Medica, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy

Received 10 March 2014; Revised 9 May 2014; Accepted 12 May 2014; Published 29 May 2014

Academic Editor: Ozcan Erel

Copyright © 2014 Cinzia Signorini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Hagberg, J. Aicardi, K. Dias, and O. Ramos, “A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: rett's syndrome: report of 35 cases,” Annals of Neurology, vol. 14, no. 4, pp. 471–479, 1983. View at Google Scholar · View at Scopus
  2. T. Bienvenu, C. Philippe, N. De Roux et al., “The incidence of rett syndrome in France,” Pediatric Neurology, vol. 34, no. 5, pp. 372–375, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Hagberg, “Clinical manifestations and stages of Rett syndrome,” Mental Retardation and Developmental Disabilities Research Reviews, vol. 8, no. 2, pp. 61–65, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. R. E. Amir, I. B. Van den Veyver, M. Wan, C. Q. Tran, U. Francke, and H. Y. Zoghbi, “Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl—CpG—binding protein 2,” Nature Genetics, vol. 23, no. 2, pp. 185–188, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Christodoulou, A. Grimm, T. Maher, and B. Bennetts, “RettBASE: the IRSA MECP2 variation database-a new mutation database in evolution,” Human Mutation, vol. 21, no. 5, pp. 466–472, 2003. View at Google Scholar · View at Scopus
  6. B. Halliwell, “Oxidative stress and cancer: have we moved forward?” The Biochemical Journal, vol. 401, no. 1, pp. 1–11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Halliwell, “Free radicals and antioxidants—quo vadis?” Trends in Pharmacological Sciences, vol. 32, no. 3, pp. 125–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Halliwell, Free Radicals in Biology and Medicine, Oxford University Press, Oxford, UK, 4th edition, 2007.
  9. C. D. Aluise, R. A. S. Robinson, J. Cai, W. M. Pierce, W. R. Markesbery, and D. A. Butterfield, “Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI,” Journal of Alzheimer's Disease, vol. 23, no. 2, pp. 257–269, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A.-M. Enciu, M. Gherghiceanu, and B. O. Popescu, “Triggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegeneration,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 297512, 12 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. J. C. Brazil, N. A. Louis, and C. A. Parkos, “The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease,” Inflammatory Bowel Diseases, vol. 19, no. 7, pp. 1556–1565, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Ghezzo, P. Visconti, P. M. Abruzzo et al., “Oxidative stress and erythrocyte membrane alterations in children with autism: correlation with clinical features,” PLoS ONE, vol. 8, no. 6, Article ID e66418, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Ciccoli, C. De Felice, E. Paccagnini et al., “Erythrocyte shape abnormalities, membrane oxidative damage, and β-actin alterations: an unrecognized triad in classical autism,” Mediators of Inflammation, vol. 2013, Article ID 432616, 11 pages, 2013. View at Publisher · View at Google Scholar
  14. A. Pecorelli, S. Leoncini, C. De Felice et al., “Non-protein-bound iron and 4-hydroxynonenal protein adducts in classic autism,” Brain and Development, vol. 35, no. 2, pp. 146–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Chauhan, T. Audhya, and V. Chauhan, “Brain region-specific glutathione redox imbalance in autism,” Neurochemical Research, vol. 37, no. 8, pp. 1681–1689, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. J. James, S. Rose, S. Melnyk et al., “Cellular and mitochondrial glutathione redox imbalance in lymphoblastoid cells derived from children with autism,” FASEB Journal, vol. 23, no. 8, pp. 2374–2383, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Baio, “Prevalence of autism spectrum disorders—autism and developmental disabilities monitoring network, 14 sites, United States, 2008,” Morbidity and Mortality Weekly Report, vol. 61, no. 3, pp. 1–19, 2012. View at Google Scholar · View at Scopus
  18. S. J. James, P. Cutler, S. Melnyk et al., “Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism,” The American Journal of Clinical Nutrition, vol. 80, no. 6, pp. 1611–1617, 2004. View at Google Scholar · View at Scopus
  19. E. Grillo, C. Lo Rizzo, L. Bianciardi et al., “Revealing the complexity of a monogenic disease: Rett syndrome exome sequencing,” PLoS ONE, vol. 8, no. 2, Article ID e56599, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Großer, U. Hirt, O. A. Janc et al., “Oxidative burden and mitochondrial dysfunction in a mouse model of Rett syndrome,” Neurobiology of Disease, vol. 48, no. 1, pp. 102–114, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. C. De Felice, C. Signorini, T. Durand et al., “Partial rescue of Rett syndrome by ω-3 polyunsaturated fatty acids (PUFAs) oil,” Genes and Nutrition, vol. 7, no. 3, pp. 447–458, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Ciccoli, C. De Felice, E. Paccagnini et al., “Morphological changes and oxidative damage in Rett Syndrome erythrocytes,” Biochimica et Biophysica Acta: General Subjects, vol. 1820, no. 4, pp. 511–520, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Leoncini, C. De Felice, C. Signorini et al., “Oxidative stress in Rett syndrome: natural history, genotype, and variants,” Redox Report, vol. 16, no. 4, pp. 145–153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. C. De Felice, C. Signorini, T. Durand et al., “F2-dihomo-isoprostanes as potential early biomarkers of lipid oxidative damage in Rett syndrome,” Journal of Lipid Research, vol. 52, no. 12, pp. 2287–2297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. C. De Felice, L. Ciccoli, S. Leoncini et al., “Systemic oxidative stress in classic Rett syndrome,” Free Radical Biology and Medicine, vol. 47, no. 4, pp. 440–448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. De Felice, C. Signorini, S. Leoncini et al., “The role of oxidative stress in Rett syndrome: an overview,” Annals of the New York Academy of Sciences, vol. 1259, no. 1, pp. 121–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Renieri, F. Mari, M. A. Mencarelli et al., “Diagnostic criteria for the Zappella variant of Rett syndrome (the preserved speech variant),” Brain and Development, vol. 31, no. 3, pp. 208–216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Dracopoli, J. Haines, B. Korf et al., Current Protocols in Human Genetics, John Wiley & Sons, New York, NY, USA, 2000.
  29. C. Signorini, L. Ciccoli, S. Leoncini et al., “Free iron, total F2-isoprostanes and total F4-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatonin,” Journal of Pineal Research, vol. 46, no. 2, pp. 148–154, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Signorini, M. Comporti, and G. Giorgi, “Ion trap tandem mass spectrometric determination of F2-isoprostanes,” Journal of Mass Spectrometry, vol. 38, no. 10, pp. 1067–1074, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. C. Signorini, C. De Felice, S. Leoncini et al., “F4-neuroprostanes mediate neurological severity in Rett syndrome,” Clinica Chimica Acta, vol. 412, no. 15-16, pp. 1399–1406, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Tietze, “Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues,” Analytical Biochemistry, vol. 27, no. 3, pp. 502–522, 1969. View at Google Scholar · View at Scopus
  33. M. A. Baker, G. J. Cerniglia, and A. Zaman, “Microtiter plate assay for the measurement of glutathione and glutathione disulfide in large numbers of biological samples,” Analytical Biochemistry, vol. 190, no. 2, pp. 360–365, 1990. View at Google Scholar · View at Scopus
  34. G. Valacchi, A. Pecorelli, C. Signorini et al., “4HNE protein adducts in autistic spectrum disorders: rett syndrome and autism,” in Comprehensive Guide to Autism, V. B. Patel, V. R. Preedy, and C. R. Martin, Eds., pp. 2667–2687, Springer, New York, NY, USA, 2014. View at Google Scholar
  35. C. Signorini, C. De Felice, T. Durand et al., “Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? focus on Rett syndrome as a model of autism spectrum disorder,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 343824, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Sticozzi, G. Belmonte, A. Pecorelli et al., “Scavenger receptor B1 post-translational modifications in Rett syndrome,” FEBS Letters, vol. 587, no. 14, pp. 2199–2204, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Miyake, C. Yang, Y. Minakuchi et al., “Comparison of genomic and epigenomic expression in monozygotic twins discordant for rett syndrome,” PLoS ONE, vol. 8, no. 6, Article ID e66729, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Amenduni, R. De Filippis, A. Y. L. Cheung et al., “IPS cells to model CDKL5-related disorders,” European Journal of Human Genetics, vol. 19, no. 12, pp. 1246–1255, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Delépine, J. Nectoux, N. Bahi-Buisson, J. Chelly, and T. Bienvenu, “MeCP2 deficiency is associated with impaired microtubule stability,” FEBS Letters, vol. 587, no. 2, pp. 245–253, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Nectoux, C. Florian, C. Delepine et al., “Altered microtubule dynamics in Mecp2-deficient astrocytes,” Journal of Neuroscience Research, vol. 90, no. 5, pp. 990–998, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Vecsler, B. Ben Zeev, I. Nudelman et al., “Ex vivo treatment with a novel synthetic aminoglycoside NB54 in primary fibroblasts from Rett syndrome patients suppresses MECP2 nonsense mutations,” PLoS ONE, vol. 6, no. 6, Article ID e20733, 2011. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Sandi, M. Sandi, H. Jassal et al., “Generation and characterisation of friedreich ataxia YG8R mouse fibroblast and neural stem cell models,” PLoS ONE, vol. 9, no. 2, Article ID e89488, 2014. View at Google Scholar
  43. A. Ferretta, A. Gaballo, P. Tanzarella et al., “Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease,” Biochimica et Biophysica Acta, vol. 1842, no. 7, pp. 902–915, 2014. View at Google Scholar
  44. D. M. Boesten, J. M. de Vos-Houben, L. Timmermans, G. J. den Hartog, A. Bast, and G. J. Hageman, “Accelerated aging during chronic oxidative stress: a role for PARP-1,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 680414, 10 pages, 2013. View at Publisher · View at Google Scholar
  45. G.-Y. Yang, C.-L. Zhang, X.-C. Liu, G. Qian, and D.-Q. Deng, “Effects of cigarette smoke extracts on the growth and senescence of skin fibroblasts in vitro,” International Journal of Biological Sciences, vol. 9, no. 6, pp. 613–623, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Yang, C. Liu, D. Yang, H. Zhang, and Z. Xi, “Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition,” Journal of Applied Toxicology, vol. 29, no. 1, pp. 69–78, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Huang and R. Ogawa, “Roles of lipid metabolism in keloid development,” Lipids in Health and Disease, vol. 12, no. 1, article 60, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. E. S. Musiek, H. Yin, G. L. Milne, and J. D. Morrow, “Recent advances in the biochemistry and clinical relevance of the isoprostane pathway,” Lipids, vol. 40, no. 10, pp. 987–994, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. L. J. Roberts II, J. P. Fessel, and S. S. Davies, “The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation,” Brain Pathology, vol. 15, no. 2, pp. 143–148, 2005. View at Google Scholar · View at Scopus
  50. L. Ciccoli, S. Leoncini, C. Signorini, and M. Comporti, “Iron and erythrocytes: physiological and pathophysiological aspects,” in Oxidants in Biology, G. Valacchi and P. Davis, Eds., pp. 167–181, Springer, Heidelberg, Germany, 2008. View at Google Scholar
  51. S. A. Moore, E. Hurt, E. Yoder, H. Sprecher, and A. A. Spector, “Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid,” Journal of Lipid Research, vol. 36, no. 11, pp. 2433–2443, 1995. View at Google Scholar · View at Scopus
  52. E. R. Brown and P. V. Subbaiah, “Differential effects of eicosapentaenoic acid and docosahexaenoic acid on human skin fibroblasts,” Lipids, vol. 29, no. 12, pp. 825–829, 1994. View at Publisher · View at Google Scholar · View at Scopus
  53. S. P. Mahadik, S. Mukherjee, D. F. Horrobin, K. Jenkins, E. E. Correnti, and R. E. Scheffer, “Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects,” Psychiatry Research, vol. 63, no. 2-3, pp. 133–142, 1996. View at Publisher · View at Google Scholar · View at Scopus
  54. E. H. Epstein Jr. and N. H. Munderloh, “Isolation and characterization of CNBr peptides of human [α1(III)]3 collagen and tissue distribution of [α1(I)]2α2 and [α1(III)]3 collagens,” Journal of Biological Chemistry, vol. 250, no. 24, pp. 9304–9312, 1975. View at Google Scholar · View at Scopus
  55. L.-J. Min, T.-X. Cui, Y. Yahata et al., “Regulation of collagen synthesis in mouse skin fibroblasts by distinct angiotensin II receptor subtypes,” Endocrinology, vol. 145, no. 1, pp. 253–260, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. B. R. Olsen, “The roles of collagen genes in skeletal development and morphogenesis,” Experientia, vol. 51, no. 3, pp. 194–195, 1995. View at Publisher · View at Google Scholar · View at Scopus
  57. R. S. Wong, F. M. Follis, B. K. Shively, and J. A. Wernly, “Osteogenesis imperfecta and cardiovascular diseases,” The Annals of Thoracic Surgery, vol. 60, no. 5, pp. 1439–1443, 1995. View at Publisher · View at Google Scholar · View at Scopus
  58. E. Vuorio and B. de Crombrugghe, “The family of collagen genes,” Annual Review of Biochemistry, vol. 59, pp. 837–872, 1990. View at Google Scholar · View at Scopus
  59. K. Piez and A. Reddi, Eds., Extracellular Matrix Biochemistry, Elsevier, New York, NY, USA, 1984.
  60. R. Mayne and R. Burgeson, Eds., Structure and Function of Collagen Types, Academic Press, New York, NY, USA, 1987.
  61. P. Bornstein and H. Sage, “Structurally distinct collagen types,” Annual Review of Biochemistry, vol. 49, pp. 957–1003, 1980. View at Google Scholar · View at Scopus
  62. R. Fleischmajer, B. R. Olsen, R. Timpl, J. S. Perlish, and O. Lovelace, “Collagen fibril formation during embryogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 11, pp. 3354–3358, 1983. View at Google Scholar · View at Scopus
  63. E. Cardaioli, M. T. Dotti, G. Hayek, M. Zappella, and A. Federico, “Studies on mitochondrial pathogenesis of Rett syndrome: ultrastructural data from skin and muscle biopsies and mutational analysis at mtDNA nucleotides 10463 and 2835,” Journal of Submicroscopic Cytology and Pathology, vol. 31, no. 2, pp. 301–304, 1999. View at Google Scholar · View at Scopus
  64. G. Stabellini, G. Berti, C. Calastrini et al., “Experimental model for studying the effects of 2-ethylhexyl-phthalate and dialysate on connective tissue,” The International Journal of Artificial Organs, vol. 23, no. 5, pp. 305–311, 2000. View at Google Scholar · View at Scopus
  65. G. Ellender and K. N. Ham, “Connective tissue responses to some heavy metals. III silver and dietary supplements of ascorbic acid. Histology and ultrastructure,” British Journal of Experimental Pathology, vol. 70, no. 1, pp. 21–39, 1989. View at Google Scholar · View at Scopus
  66. V. M. Korkhov, “GFP-LC3 labels organised smooth endoplasmic reticulum membranes independently of autophagy,” Journal of Cellular Biochemistry, vol. 107, no. 1, pp. 86–95, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. G. J. Fisher, T. Quan, T. Purohit et al., “Collagen fragmentation promotes oxidative stress and elevates matrix metalloproteinase-1 in fibroblasts in aged human skin,” American Journal of Pathology, vol. 174, no. 1, pp. 101–114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. W. Xia, C. Hammerberg, Y. Li et al., “Expression of catalytically active matrix metalloproteinase-1 in dermal fibroblasts induces collagen fragmentation and functional alterations that resemble aged human skin,” Aging Cell, vol. 12, no. 4, pp. 661–671, 2013. View at Publisher · View at Google Scholar · View at Scopus
  69. B. Hagberg, “Rett syndrome: long-term clinical follow-up experiences over four decades,” Journal of Child Neurology, vol. 20, no. 9, pp. 722–727, 2005. View at Google Scholar · View at Scopus
  70. N. Halbach, E. Smeets, C. Steinbusch, M. Maaskant, D. van Waardenburg, and L. Curfs, “Aging in Rett syndrome: a longitudinal study,” Clinical Genetics, vol. 84, no. 3, pp. 223–229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. C. S. Ward, E. M. Arvide, T.-W. Huang, J. Yoo, J. L. Noebels, and J. L. Neul, “MeCP2 is critical within HoxB1-derived tissues of mice for normal lifespan,” Journal of Neuroscience, vol. 31, no. 28, pp. 10359–10370, 2011. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Squillaro, N. Alessio, M. Cipollaro et al., “Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence: new perspective for Rett syndrome,” Molecular Biology of the Cell, vol. 23, no. 8, pp. 1435–1445, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. S. Dato, P. Crocco, P. D. 'Aquila et al., “Exploring the role of genetic variability and lifestyle in oxidative stress response for healthy aging and longevity,” International Journal of Molecular Sciences, vol. 14, no. 8, pp. 16443–16472, 2013. View at Google Scholar
  74. S. I. Liochev, “Reactive oxygen species and the free radical theory of aging,” Free Radical Biology and Medicine, vol. 60, pp. 1–4, 2013. View at Publisher · View at Google Scholar · View at Scopus